Cardinal health reports third quarter fiscal year 2024 results and raises fiscal year 2024 non-gaap eps guidance

Revenue increased 9% to $54.9 billion gaap1 operating earnings were $367 million; gaap diluted eps was $1.05 non-gaap operating earnings increased 10% to $666 million; non-gaap diluted eps increased 20% to $2.08 fiscal year 2024 non-gaap eps guidance 2 raised and narrowed to $7.30 to $7.40, from $7.20 to $7.35 company provides preliminary fiscal year 2025 non-gaap eps guidance of at least $7.50 dublin, ohio , may 2, 2024  /prnewswire/ -- cardinal health (nyse: cah) today reported third quarter fiscal year 2024 revenues of $54.9 billion, an increase of 9% from the third quarter of fiscal year 2023. third quarter gaap operating earnings were $367 million and gaap diluted earnings per share (eps) were $1.05, which included a non-cash, pre-tax goodwill impairment of $90 million related to the global medical products and distribution (gmpd) segment as a result of the reallocation of goodwill related to the reporting structure update.
CAH Ratings Summary
CAH Quant Ranking